Drug
Amt 143
Amt 143: highest development phase Phase 2, developed by AmacaThera Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- AmacaThera Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| AMT-143 NCT07858734 | Phase 2 | Bunionectomy |
Latest
No recent events.
Follow Amt 143 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.